- Home
- NRK vs ORGO Comparison
NRK vs ORGO Comparison
Compare NRK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRK | ORGO |
|---|---|---|
| Founded | 2002 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 878.5M | 732.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRK | ORGO |
|---|---|---|
| Price | $10.18 | $4.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 187.3K | ★ 1.5M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $465,218,000.00 |
| Revenue This Year | N/A | $8.14 |
| Revenue Next Year | N/A | $6.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.24 |
| 52 Week Low | $8.95 | $2.61 |
| 52 Week High | $11.09 | $7.08 |
Technical Indicators
Market Signals| Indicator | NRK | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.35 | 32.59 |
| Support Level | $10.09 | $4.24 |
| Resistance Level | $10.17 | $4.40 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 90.00 | 3.16 |
Price Performance
Historical ComparisonAbout NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.